RSS Alerts

Events & Training for March 2014

Superbugs and Superdrugs

05 March 2014 - 06 March 2014

This exciting event will bring together industry leaders from big pharma companies, biotech companies, regulatory agencies and academia to discuss the latest development in the antibacterial market. This unique conference will present attendees with a complete view into the latest research in combating multi-drug resistance. The conference will also address the main challenges that pharmaceutical companies are currently facing in terms of funding and low unit price of antibiotics and will look at how these companies can go into partnerships and have access to funds and wider expertise. The conference will be made up of a number of presentations and case studies from key opinion leaders and updates on their latest research projects and real life success stories for all attendees to learn from.

Holiday Inn Regents Park, London, UK

Controlled Release

12 March 2014 - 13 March 2014

SMi is proud to present its 11th annual controlled release conference, held in central London on the 12 & 13 March 2014. The meeting will continue in a long tradition of critically acclaimed speakers who are pioneers in their field. This event offers you a unique opportunity to keep up to date with the latest in technologies and methods such as the diffusion of nanomaterials through biological and non-biological gels.

VenueHoliday Inn Regents Park, London, UK

Controlled Release

12 March 2014 - 13 March 2014

SMi is proud to present its 11th annual controlled release conference, held in central London on the 12 & 13 March 2014. The meeting will continue in a long tradition of critically acclaimed speakers who are pioneers in their field. This event offers you a unique opportunity to keep up to date with the latest in technologies and methods such as the diffusion of nanomaterials through biological and non-biological gels.

Holiday Inn Regents Park, London, UK

Maximising the Value of Imaging in Oncology Drug Development

12 March 2014 - 13 March 2014

Imaging allows us to answer questions that we did not know the answer to before. For example, it can help determine the composition of the tumour, clinical evaluation of patients and evaluation of new treatments. Imaging within the arena of personalised healthcare is an area of increasing significance and will revolutionise the field of oncology. The event will focus on innovative imaging and effective strategies for success in oncology drug development. Both pre-clinical and clinical use of imaging will be examined.

Holiday Inn Regents Park, London, UK

Reducing Attrition through Early Assessment of Drug Safety

13 March 2014

Drug toxicity remains one of the main causes of compound attrition in the drug development process. Compounds displaying organ, mechanism-based or off-target toxicity are just some of the safety issues that have contributed to drug development failures, and the need for robust early drug safety screening in an integrative manner is clear. In the last decade, an increased understanding of the molecular basis for some of these toxicities and the advancement of technologies designed to screen for them has improved options for screening out potential compound liabilities earlier in the research phase. Advances include the use of human induced pluripotent stem cells and miniaturised mimics of human organs. New markers of toxicity are being investigated at the RNA level, using metabolomics and through application of bioinformatic approaches. In addition, technologies have been developed to gather data on broad compound promiscuity at the protein level using panels of off-target activity as markers of general promiscuity. This meeting will bring together a range of international experts from both industry and academia to present the new technologies and their applications in early drug safety assessment. The meeting will be of great interest to anyone involved in drug discovery and development, or has an interest in the science behind drug safety screening

The National Heart and Lung Institute, Kensington, London, UK

Targeting Mitochondrial Dysfunction & Toxicity

19 March 2014 - 20 March 2014

Mitochondrial dysfunction has been identified as an important factor in diseases ranging from neurodegenerative conditions (ALS, Alzheimer's, Parkinson's Disease), epilepsy, psychiatric illness and autism, to cardiovascular disease, liver/kidney disease, diabetes and cancer. The wide-ranging impact of mitochondria in so many diseases makes them prime targets for therapeutics. Additionally, medications for many diseases cause unwanted toxicity to the mitochondria. Mitochondrial toxicity is one of the leading causes of attrition in the drug development process, as well as in post-market drug withdrawals. Targeting Mitochondrial Dysfunction & Toxicity (the first conference of its kind in the US) will present the latest research in new targeting pathways, novel therapeutics, and methods to decrease or eliminate mitochondrial toxicity when developing therapeutics for many indications.

Omni Parker House, Boston, MA, USA

Biochemical Journal Symposium 2014: Human Therapeutics: Where Biology Meets Chemistry

20 March 2014

Following on from the Biochemical Journal's two highly successful one-day Symposia, this third Symposium is centred on drug discovery in academia - an area which is growing rapidly. This timely meeting, featuring twelve expert speakers in their respective fields, will focus on the use of chemical biology to foster drug discovery in the academic environment.

Holiday Inn Bloomsbury, London, UK

Adaptive Designs in Clinical Trials

24 March 2014 - 25 March 2014

Due to major changes that have been applied to clinical trials over recent years by both biotech and pharmaceutical companies, the importance of adaptive designs to clinical trials has become more apparent to the industry. The time and cost reductions in the early phase of clinical trials enables less recruitment of patients and improves the general accuracy in clinics. Successful implementation of adaptive designs into a trial however requires unmatched coordination between clinicians, trial managers, statisticians and those involved in the regulation process. Hear through case studies how all sizes of pharmaceutical companies have successfully implemented trials incorporating adaptive designs. This conference is the only in Europe that focuses on adaptive designs specifically, providing delegates with updates on recent developments in enrichment design, dose response modelling, computer simulation, internal and external regulatory expectations and new data on evaluating adaptive dose ranging studies.

Holiday Inn Regents Park, London, UK

Paediatric Clinical Trials

24 March 2014 - 25 March 2014

Holiday Inn Regents Park, London, UK

Adaptive Designs in Clinical Trials

24 March 2014 - 25 March 2014

Due to major changes that have been applied to clinical trials over recent years by both biotech and pharmaceutical companies, the importance of adaptive designs to clinical trials has become more apparent to the industry. The time and cost reductions in the early phase of clinical trials enables less recruitment of patients and improves the general accuracy in clinics. Successful implementation of adaptive designs into a trial however requires unmatched coordination between clinicians, trial managers, statisticians and those involved in the regulation process. Hear through case studies how all sizes of pharmaceutical companies have successfully implemented trials incorporating adaptive designs. This conference is the only in Europe that focuses on adaptive designs specifically, providing delegates with updates on recent developments in enrichment design, dose response modelling, computer simulation, internal and external regulatory expectations and new data on evaluating adaptive dose ranging studies.

Holiday Inn Regents Park, London, UK

Discovery Summit 2014

31 March 2014 - 01 April 2014

The 14th Annual Global Discovery Summit is the premium forum bringing elite buyers and sellers together. As an invitation-only event taking place behind closed doors, the summit offers global R&D professionals and drug discovery service providers an intimate environment for a focused discussion of key new drivers shaping discovery research and development.

Grande Real Villa Itália Hotel & Spa, Cascais, Lisbon

Pre-Filled Syringes Americas

31 March 2014 - 01 April 2014

With unit sales of 3.59 billion predicted in 2015, pre-filled syringes form one of the fastest growing markets in healthcare. The companies that will thrive in this marketplace will be those able to deliver products to market with the shortest lead times and longest shelf life. Pre-Filled Syringes Americas is the western hemisphere's industry forum. The world’s biopharmaceutical companies will be gathering to discuss how the latest developments in drug stabilisation and material interactions are reshaping the drug delivery industry.

Renaissance Woodbridge Hotel, Iselin, New Jersey, USA

Copyright © 2025
Elsevier Ltd. All rights reserved.
Sitemap | Terms & Conditions | Privacy | | Website Design Working with water